A standard-dose recombinant growth hormone therapy administered for 2 years demonstrated positive effects on both growth and nutritional status in prepubertal children with Silver-Russell syndrome, a ...

For parents whose children are undergoing growth hormone therapy, the focus might be on height and physical development, but ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...

A child’s height reflects more than genes, hormones, nutrition, and physical activity all play key roles. Supporting these ...

Pfizer Inc. PFE said Wednesday the U.S. Food and Drug Administration has approved its Ngenla once-weekly, human growth hormone treatment for children aged three and older who have growth failure due ...

NEW YORK (Reuters Health) - Type 2 diabetes is eight and a half times more common among children in the United States treated with growth hormone than among kids who are not on the hormone treatment, ...

SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Australian registration of SKYTROFA® (lonapegsomatropin) as a new ...

Short in height and confidence, two kids take HGH with high hopes. Did it work? July 23, 2007— -- Are you too short? Missing out on opportunities because tall people have an advantage? What if, ...

A child's healthy growth is a complex interplay of genetics, hormones and nutrition. Experts emphasize that factors like ...

Winston Hall, 9, needs growth hormone to manage symptoms of Prader-Willi syndrome, a genetic condition. A shortage of the medicine has contributed to behavioral issues that led him to be sent home ...

Researchers at University College London (UCL) suspect that the growth hormone received in childhood may have contained amyloid-beta protein plaques, which build up in the brains of people with ...

SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[1] "We are delighted to have secured TGA ...